THE ROBO GLOBAL APPROACH

    Technological disruption is currently driving compelling yet complex investment opportunities across robotics, artificial intelligence, and healthcare technology. Our ETFs are constructed based on fundamental and industry research by a team of financial and industry experts.

    1
    Team of Experts

    Our coverage team incorporates full-time financial and research professionals supported by industry entrepreneurs and academic leaders who specialize in global developments across disruptive tech. Our strategic advisory board includes PhDs and respected tech visionaries.

    2
    Methodology

    Our team established an index methodology and classification system that provides diversified exposure to disruptive technologies. Our ETFs are built to minimize risk by limiting reliance on largest-cap players and to capture the potential growth of global, developing technology companies.

    3
    Research

    Our ETFs are constructed based on fundamental and industry research. Our team conducts deep research, working to identify new trends, understand new innovations, and explore every company on the radar -- regardless of size, market cap, or technology.

    How to Invest
    HubSpot Video

    News Feed

    Turnkey Tech Investing: Feb 2023 Market Brief
    Turnkey Tech Investing: Feb 2023 Market Brief

    By Bill Studebaker, CIO & President, ROBO Global 

    Read More
    How Liquid Biopsy Is Bringing Earlier Cancer Detection to the Horizon
    How Liquid Biopsy Is Bringing Earlier Cancer Detection to the Horizon

    While much of the healthcare industry’s attention over the past two years has been fixated on...

    Read More
    Turnkey Tech Investing: Jan 2023 Market Brief
    Turnkey Tech Investing: Jan 2023 Market Brief

    By Bill Studebaker, CIO & President, ROBO Global 

    Read More
    6927 Investing in Healthcare Technology_V001_A

    Healthcare Innovation From An Investor's Perspective

    The convergence of robotics, machine intelligence, and life sciences is enabling breakthrough advancements that touch every aspect of healthcare. While the list of innovations is vast, these technologies are still in their earliest stages. The emerging winners of this disruption will be those companies that are able to effectively deploy innovations such as genomics, precision medicine, or robotics, automation, and AI (RAAI) to improve the quality of care while reducing costs.

    Download Investment Case

     

    6640 Responsibly connecting and empowering disciplines through the use of AI & computing tools_V001

    The How & Why of Investing in AI

    AI is a critical theme for future-focused investing. The simulation of human intelligence processes by computer systems, AI uses machine learning and deep learning to enable systems to learn by themselves with little to no human intervention. And while machine intelligence has been around since the 1950s, it has recently hit an inflection point, moving from the experimental phase to an era of practical commercial application.

    Download Investment Case

    logo-white

    Providing investors with a liquid, cost-effective and diversified way
    to gain access to rapidly evolving robotics technology and AI

    Navigation

        contacts

        © 2013 - 2022 ROBO Global ETFs. All rights reserved.

        Exchange Traded Concepts, LLC serves as the investment advisor of the funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Exchange Traded Concepts, LLC or any of its affiliates. Check the background of SIDCO on FINRA’s BrokerCheck.

        Carefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found on the Funds' full or summary prospectuses, which may be obtained at www.roboglobaletfs.com. Read the prospectus carefully before investing.

        Investing involves risk, including the possible loss of principal. International investments may also involve risk from unfavorable fluctuations in currency values, differences in generally accepted accounting principles, and from economic or political instability. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Narrowly focused investments and investments in smaller companies typically exhibit higher volatility. There is no guarantee the funds will achieve their stated objective. ROBO, HTEC, and THNQ are non-diversified.

        The liquidity of the A-shares market and trading prices of A-shares could be more severely affected than the liquidity and trading prices of other markets because the Chinese government restricts the flow of capital into and out of the A-shares market. The funds may experience losses due to illiquidity of the Chinese securities markets or delay or disruption in execution or settlement of trades.

        The risks associated with investments in Robotics and Automation Companies include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation. Robotics and Automation Companies, especially smaller, start-up companies, tend to be more volatile than securities of companies that do not rely heavily on technology. Rapid change to technologies that affect a company's products could have a material adverse effect on such company's operating results. Robotics and Automation Companies may rely on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their proprietary rights in their products and technologies. There can be no assurance that the steps taken by these companies to protect their proprietary rights will be adequate to prevent the misappropriation of their technology or that competitors will not independently develop technologies that are substantially equivalent or superior to such companies' technology.

        The risks associated with Artificial Intelligence (AI) Companies include, but are not limited to, small or limited markets, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation. Rapid change to technologies that affect a company’s products could have a material adverse effect on such company’s operating results. AI Companies also rely heavily on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their proprietary rights in their products and technologies. There can be no assurance that the steps taken by these companies to protect their proprietary rights will be adequate to prevent the misappropriation of their technology or that competitors will not independently develop technologies that are substantially equivalent or superior to such companies’ technology. AI Companies typically engage in significant amounts of spending on research and development, and there is no guarantee that the products or services produced by these companies will be successful.

        The risks associated with Medical Technology Companies include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation.

        Diversification may not protect against market risk.

        Privacy Policy

        Beginning September 2, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to September 2, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times.